Company Number: 13910580

Analysis Date: 2025-07-20 16:58 UTC

Financial Health Assessment for Contrast Diagnostics Omicron Ltd

---

1. Financial Health Score: D

Explanation:
The company’s financials show minimal activity and extremely limited asset base (£1,000 in debtors and shareholders' funds consistently). The absence of turnover, profits, or any tangible growth, alongside dormant status indications, signals a fragile financial condition. While not insolvent or in distress, the company exhibits symptoms akin to a patient with very low vitality and no active economic engagement.

---

2. Key Vital Signs

Metric	Value	Interpretation
Total Assets Less Current Liabilities	£1,000	Extremely low asset base, suggesting minimal operational scale or activity.
Shareholders' Funds (Equity)	£1,000	Equity matches net assets; no retained earnings or reserves, indicating no profitability history.
Debtors (Amounts owed to company)	£1,000	Debtors equal total assets, implying no other assets like cash or inventory; possibly uncollected funds or prepayments.
Employees	Nil	No staff employed, indicating no operational workforce or business activity.
Dormant Status	Dormant (not explicitly stated but implied)	Company has been dormant throughout reported periods, with no trading activity.
Audit and Reporting	Exempt from audit; unaudited accounts	Small company exemption used, but no profit and loss statement filed due to dormancy.

---

3. Diagnosis

Contrast Diagnostics Omicron Ltd resembles a patient in a state of metabolic inactivity—a business entity effectively dormant for multiple financial years. The static balance sheet with only nominal amounts, no employees, and absence of trading activity suggests the company is not currently generating revenue or incurring expenses.

This "dormant" symptom profile means the company is not actively operating its specialist medical practice as per its SIC code (86220). The financial "pulse" is faint, with no cash flow, no working capital beyond nominal debtors, and no equity growth. The sole director and 100% shareholder is maintaining the entity, possibly for future activation or to hold an asset or name.

There is no evidence of financial distress (no liabilities exceeding assets, no negative equity), but also no signs of financial health such as profitability, liquidity, or operational momentum. The company is in a state of financial stasis.

---

4. Recommendations

• Activate Business Operations or Close: If the company intends to pursue active operations, it must develop a business plan, generate revenue, and invest in assets and personnel. Without these, the company risks incurring fixed costs without income.

• Improve Financial Transparency: Even if dormant, consider filing fuller accounts with income statements for clarity and future lender/investor confidence.

• Review Capitalization: The minimal equity suggests limited financial buffer. Injection of capital or loans may be necessary before business activities can commence.

• Manage Administrative Compliance: Continue timely filing of confirmation statements and accounts to avoid penalties and maintain good standing.

• Consider Dormant Company Status: If no trading is planned, formally designate the company as dormant to simplify reporting and reduce compliance burden.

• Plan for Future Growth: If the company is a shell for future operations, establish clear timelines and financial targets to transition from dormancy to active trading.

---

Medical Analogy Summary:
Contrast Diagnostics Omicron Ltd is akin to a patient in deep hibernation—no metabolic activity, minimal vital signs, and stable but very low energy reserves. Without intervention (capital infusion, operational start-up), the prognosis is limited to continued dormancy or eventual dissolution.

---